Modification of gastric pH in the fasted dog

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 4, 2010, Pages 462-469

  Polentarutti, Britta ^a   Albery, Tamsin ^a   Dressman, Jennifer ^b   Abrahamsson, Bertil ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Dogs; Gastric pH; Omeprazole; Pentagastrin; Ranitidine

Indexed keywords

CITRIC ACID; GLYCINE; HYDROCHLORIC ACID; OMEPRAZOLE; PENTAGASTRIN; POTASSIUM CHLORIDE; RANITIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; EXPERIMENTAL DOG; FOOD DRUG INTERACTION; GASTRIC PH MONITORING; MALE; NONHUMAN; REACTION TIME; STOMACH EMPTYING; STOMACH PH;

EID: 77952842164     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.04.0008     Document Type: Article

References (18)

1. Dressman JB Comparison of canine and human gastrointestinal physiology J Pharm Sci 1986 3 : 123 131.
2. Lui CY et al. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans J Pharm Sci 1986 75 : 271 274.
3. Dressman JB et al. Upper gastrointestinal pH in young, healthy men and women Pharm Res 1990 7 : 756 761.
4. Kanerva H et al. Different absorption profiles of deramciclane in man and in dog J Pharm Pharmacol 1998 50 : 1087 1093.
5. Yamada I et al. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric-acidity-controlled beagle dogs Chem Pharm Bull 1990 38 : 3112 3115.
6. Sagara K et al. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules Biol Pharm Bull 1996 19 : 1184 1188.
7. Akimoto M et al. Gastric pH profiles of beagle dogs and their use as an alternative to human testing Eur J Pharm Biopharm 2000 49 : 99 102.
8. Kromer W et al. Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles Pharmacology 2000 60 : 179 187.
9. Wilsson-Rahmberg M, Jonsson O Method for long-term intestinal access in the dog Lab Anim 1997 31 : 231 240.
10. Mummaneni V et al. Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs Pharm Res 1995 12 : 780 786.
11. Lin JH et al. pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs Drug Metab Dispos 1995 23 : 730 735.
12. Bergegårdh S et al. The effect of intragastric neutralization on the gastric acid response to antral distension in man Scand J Gastroenterol 1975 5 : 625 631.
13. Vashi VI, Meyer MC Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs J Pharm Sci 1988 77 : 760 764.
14. Mori C, Kondo H Effect of gastric acidity regulation on the gastrointestinal transit time and secretion of gastric fluids in beagle dogs J Drug Del Sci Tech 2006 16 : 467 472.
15. Ajayi FO et al. Absolute bioavailability of halofantrine-HCl: effect of ranitidine and pentagastrin treatment Clin Res Reg Aff 1999 16 : 13 28.
16. Cundy KC et al. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs J Pharm Sci 1997 86 : 1334 1338.
17. Sagara K et al. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs Chem Pharm Bull 1992 40 : 3303 3306.
18. Knupp CA et al. Biopharmaceutics of didanosine in humans and in a model for acid-labile drugs, the pentagastrin-pretreated dog Pharm Res 1993 10 : 1157 1164.